IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,906 | -3.6% | 3,649 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $167,997 | +24.1% | 3,519 | +2.3% | 0.00% | 0.0% |
| Q1 2023 | $135,364 | +41.9% | 3,440 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $95,366 | -6.5% | 3,371 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | -9.7% | 3,383 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $113,000 | -19.9% | 3,336 | +6.0% | 0.00% | 0.0% |
| Q1 2022 | $141,000 | -9.6% | 3,148 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $156,000 | +33.3% | 3,371 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $117,000 | +12.5% | 3,471 | -2.3% | 0.00% | – |
| Q2 2021 | $104,000 | +18.2% | 3,553 | +3.6% | 0.00% | – |
| Q1 2021 | $88,000 | +12.8% | 3,431 | +0.3% | 0.00% | – |
| Q4 2020 | $78,000 | +4.0% | 3,422 | -2.8% | 0.00% | – |
| Q3 2020 | $75,000 | -8.5% | 3,520 | -0.6% | 0.00% | – |
| Q2 2020 | $82,000 | +43.9% | 3,543 | +31.7% | 0.00% | – |
| Q1 2020 | $57,000 | -14.9% | 2,690 | -5.5% | 0.00% | – |
| Q4 2019 | $67,000 | +11.7% | 2,846 | +0.2% | 0.00% | – |
| Q3 2019 | $60,000 | +5.3% | 2,840 | +1.3% | 0.00% | – |
| Q2 2019 | $57,000 | -10.9% | 2,803 | +22.3% | 0.00% | – |
| Q1 2019 | $64,000 | +14.3% | 2,291 | -0.6% | 0.00% | – |
| Q4 2018 | $56,000 | -34.9% | 2,305 | -0.7% | 0.00% | – |
| Q3 2018 | $86,000 | +83.0% | 2,322 | +1.8% | 0.00% | – |
| Q2 2018 | $47,000 | +113.6% | 2,281 | -8.5% | 0.00% | – |
| Q1 2017 | $22,000 | -15.4% | 2,493 | +7.2% | 0.00% | – |
| Q4 2016 | $26,000 | -99.9% | 2,326 | -0.3% | 0.00% | – |
| Q3 2016 | $39,638,000 | -21.8% | 2,333 | +0.1% | 0.00% | – |
| Q2 2016 | $50,701,000 | +58.4% | 2,330 | +41.6% | 0.00% | – |
| Q1 2016 | $32,000,000 | -30.4% | 1,646 | 0.0% | 0.00% | – |
| Q4 2015 | $46,000,000 | +114900.0% | 1,646 | -0.2% | 0.00% | – |
| Q3 2015 | $40,000 | -99.9% | 1,649 | +0.1% | 0.00% | – |
| Q2 2015 | $38,349,000 | – | 1,648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |